Activation of activating transcription factor 2 by p38 MAP kinase during apoptosis induced by human amylin in cultured pancreatic β-cells

FEBS Journal

Volumn 273, Issue 16, 2006, Pages 3779-3791

  Zhang, Shaoping ^a   Liu, Hong ^a   Liu, Junxi ^a   Tse, Cynthia A ^a   Dragunow, Michael ^b   Cooper, Garth J S ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

cell apoptosis; Activating transcription factor 2; Amylin; p38 kinase; Type 2 diabetes

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVATING TRANSCRIPTION FACTOR 2; AMYLIN; CASPASE 3; CASPASE 8 INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; CATALYSIS; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION;

ACTIVATING TRANSCRIPTION FACTOR 2; AMYLOID; APOPTOSIS; CELLS, CULTURED; HUMANS; INSULIN-SECRETING CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 33746782577     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05386.x     Document Type: Article

References (48)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel RA, RR & Butler PC (2003a) Beta cell deficit and increased beta-cell apoptosis in human with type 2 diabetes. Diabetes 52, 102-110.
2. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46, 3-19.
3. Cooper GJS (1994) Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocrine Rev 15, 163-201.
4. Marzban L, Park K & Verchere CB (2003) Islet amyloid polypeptide and type 2 diabetes. Exp Gerontol 38, 347-351.
5. Butler AE, Janson J, Soeller WC & Butler PC (2003b) Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes - evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52, 2304-2314.
6. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB & Reid KBM (1987) Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84, 8628-8632.
7. Lukinius A, Wilander E, Westermark GT, Engström U & Westermark P (1989) Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia 32, 240-244.
8. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD & Johnson KH (1987) Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84, 3881-3885.
9. Goldsbury CS, Cooper GJS, Goldie KN, Müller SA, Saafi EL, Gruijters WTM, Misur MP, Engel A, Aebi U & Kistler J (1997) Polymorphic fibrillar assemblies of human amylin. J Struct Biol 119, 17-27.
10. Lorenzo A, Razzaboni B, Weir GC & Yankner BA (1994) Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756-760.
11. Saafi EL, Konarkowska B, Zhang S, Kistler J & Cooper GJS (2001) Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet b-cells. Cell Biol Intl 25, 339-350.
12. Kapurniotu A (2001) Amyloidogenicity and cytotoxicity of islet amyloid polypeptide. Biopolymers 60, 438-459.
13. Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK & Butler PC (1996) Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci USA 93, 7283-7288.
14. Goldsbury C, Kistler J, Aebi U, Arvinte T & Cooper GJS (1999) Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol 285, 33-39.
15. Zhang SP, Liu JX, MacGibbon G, Dragunow M & Cooper GJS (2002) Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet beta-cells. J Mol Biol 324, 271-285.
16. Zhang SP, Liu JX, Saafi EL & Cooper GJS (1999) Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21 (WAF1/CIP1). FEBS Lett 455, 315-320.
17. Verchere CB, D'Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG & Kahn SE (1996) Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93, 3492-3496.
18. Janciauskiene S & Ahren B (2000) Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines. Biochem Biophys Res Commun 267, 619-625.
19. Sparr E, Engel MFM, Sakharov DV, Sprong M, Jacobs J, de Kruijff B, Hoppener JWM & Killian JA (2004) Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett 577, 117-120.
20. Janson J, Ashley RH, Harrison D, McIntyre S & Butler PC (1999) The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491-498.
21. Demuro A, Mina E, Kayed R, Milton SC, Parker I & Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300.
22. Konarkowska B, Aitken JF, Kistler J, Zhang S & Cooper GJS (2005) Thiol reducing compounds prevent human amylin-evoked cytotoxicity. FEBS J 272, 4949-4959.
23. Zhang SP, Liu JX, Dragunow M & Cooper GJS (2003) Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1. J Biol Chem 278, 52810-52819.
24. Rumora L, Hadzija M, Barisic K, Maysinger D & Grubiic TZ (2002) Amylin-induced cytotoxicity is associated with activation of caspase-3 and MAP kinases. Biol Chem 383, 1751-1758.
25. Cowan KJ & Storey KB (2003) Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206, 1107-1115.
26. Xia Z, Dickens M, Raingeaud J, Davis RJ & Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
27. Davis RJ (1993) The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268, 14553-14556.
28. Hill CS & Treisman R (1995) Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80, 199-211.
29. Ichijo H, Nishida E, Irie K, Dijke PT, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K & Gotoh Y (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
30. Saldeen J, Lee JC & Welsh N (2001) Role of p38 mitogen-activated protein kinase (p38 MAPK) in cytokine-induced rat islet cell apoptosis. Biochem Pharmacol 61, 1561-1569.
31. Pavlovic D, Andersen NA, Mandrup-Poulsen T & Eizirik DL (2000) Activation of extracellular signal-regulated kinase (ERK) 1/2 contributes to cytokine-induced apoptosis in purified rat pancreatic beta-cells. Eur Cytokine Network 11, 267-274.
32. Nemoto S, Xiang J, Huang S & Lin A (1998) Induction of apoptosis by SB202190 through inhibition of p38b mitogen-activated protein kinase. J Biol Chem 273, 16415-16420.
33. Nishina H, Fischer KD, Radvanyi L, Shahinian A, Hakem R, Rubie EA, Bernstein A, Mak TW, Woodgett JR & Penninger JM (1997) stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 385, 350-353.
34. Wisdom R, Johnson R, S & Moore C (1999) c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18, 188-197.
35. Maekawa T, Sakura H, Kanei-Ishii C, Sudo T, Yoshimura T, Fujisawa J, Yoshida M & Ishii S (1989) Leucine zipper structure of the protein CRE-BP1 binding to the cyclic AMP response element in brain. EMBO J 8, 2023-2028.
36. Hai T & Curran T (1991) Cross-family dimerization of transcription factor Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88, 3720-3724.
37. van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P & Angel P (1995) ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J 14, 1798-1811.
38. Walton M, Woodgate AM, Sirimanne E, Gluckman P & Dragunow M (1998) ATF-2 phosphorylation in apoptotic neuronal death. Mol Brain Res 63, 198-204.
39. Livingstone C, Patel G & Jones N (1995) ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J 14, 1785-1797.
40. Zayzafoon M, Botolin S & McCabe LR (2002) p38 and activating transcription factor-2 involvement in osteoblast osmotic response to elevated extracellular glucose. J Biol Chem 277, 37212-37218.
41. Davis RJ (1999) Signal transduction by the c-Jun N-terminal kinase. Biochem Soc Symp 64, 1-12.
42. Goldsbury C, Goldie K, Pellaud J, Seelig J, Frey P, Muller SA, Kistler J, Cooper GJS & Aebi U (2000) Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol 130, 352-362.
43. Bai JZ, Saafi EL, Zhang S & Cooper GJS (1999) Role of calcium in apoptosis evoked by human amylin in pancreatic islet b-cells. Biochem J 343, 53-61.
44. Hull RL, Westermark GT, Westermark P & Kahn SE (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89, 3629-3643.
45. Gueli N, Toto A, Palmieri G, Carmenini G, Delpino A & Ferrini U (1987) In vitro growth of a cell line originated from a human insulinoma. J Exp Clin Cancer Res 6, 281-285.
46. Baroni MG, Cavallo MG, Mark M, Monetini L, Stoehrer B & Pozzilli P (1999) Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM. J Endocrinol 161, 59-68.
47. Stadheim TA, Saluta GR & Kucera GL (2000) Role of c-Jun N-terminal kinase/p38 stress signaling in 1-β-D-arabinofuranosylcytosine-induced apoptosis. Biochem Pharmacol 59, 407-418.
48. Sambrook J, Fritsch EF & Maniatis T (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbour Laboratory, Cold Spring Harbor, NY.